Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Venn Life Sciences Holdings Plc (VENN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

Venn Life Sciences Holdings Plc (Venn Life Sciences), formerly Armscote Investment Company Plc is a contract research organization that offers drug development, clinical trial management and resourcing solutions. The organization offers drug development services such as clinical pharmacology, drug candidate selection, in-licensing and technical due diligence, non-clinical and pre-clinical development, regulatory affairs and consulting, pharmacometrics and PK and PD modelling, pharmaceutical development, and others. It offers clinical services including feasibility, regulatory affairs, project management, clinical monitoring, biometrics, interactive response technology, resourcing and recruitment, legal services and investigator initiated studies. Venn Life Sciences caters to pharmaceutical, biotechnology and medical device companies and academic organizations. It has operations in the UK, France, the Netherlands, Germany and Ireland. Venn Life Sciences is headquartered in London, the UK.

Venn Life Sciences Holdings Plc (VENN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

InnoVenn Raises USD1 Million in Venture Financing Round 12

Venn Life Sciences Raises USD 4 Million In Venture Financing 13

Partnerships 14

Venn Life Sciences Enters into Partnership with European Biotechnology Company 14

Venn Life Sciences Forms Joint Venture With Cellulac And Biopharmed West 15

Venn Life Sciences Forms Joint Venture In Russia 16

Merger 17

Venn Life Sciences And Encorium Announce Merger 17

Equity Offering 18

Venn Life Sciences Raises USD0.9 Million in Private Placement of Shares 18

Venn Life Sciences to Raise USD5.5 Million in Private Placement of Shares 19

Venn Life Sciences Raises USD3.1 Million in Private Placement of Shares 20

Venn Life Sciences Raises USD1.7 Million in Private Placement of Shares 21

Venn Life Sciences Completes IPO For USD 4 Million 22

Acquisition 24

Venn Life Sciences Holdings to Acquire Remaining 11.03% Stake in Venn Life Sciences France 24

Integumen to Acquire Innovenn UK from Venn Life Sciences and Helium Rising Stars Fund for USD6 Million 25

Venn Life Sciences Acquires Kinesis Pharma 26

Venn Life Sciences Acquires Majority Stake in Cardinal Systems 27

Venn Life Sciences Acquires Labskin, SYN1113 And Related Equipment From Evocutis For USD 0.35 Million 28

Venn Life Sciences Acquires Medevol, Clinical Research Organization, For USD 1 Million 29

Venn Life Sciences To Acquire Majority Stake In CRM Clinical Trials For USD 0.8 Million 30

Armscote Investment Company Acquires Venn Life Sciences In Reverse Take-Over Transaction For USD 4.63 Million 31

Venn Life Sciences Holdings Plc-Key Competitors 32

Venn Life Sciences Holdings Plc-Key Employees 33

Venn Life Sciences Holdings Plc-Locations And Subsidiaries 34

Head Office 34

Other Locations & Subsidiaries 34

Recent Developments 36

Financial Announcements 36

Sep 25, 2018: Venn Life Sciences Holdings: Interim Results for 6 months ended 30 June 2018 36

May 17, 2018: Venn Life Sciences Holdings: Preliminary Final Results for the year ended 31 December 2017 38

Sep 12, 2017: Venn Life Sciences Holdings Announces Half-year Report Interim Results for 6 months ended 30 June 2017 39

Jul 20, 2017: Venn Life Sciences Holdings Announces Half year end update 41

Mar 22, 2017: Venn Life Sciences Holdings Announces Final Results for the year ended 31 December 2016 42

Corporate Communications 43

Mar 21, 2018: Venn Life Sciences Holdings Announces Resignation of Director 43

Jul 25, 2017: Venn Life Sciences: Senior Management Appointment 44

Jul 25, 2017: Venn Life Sciences Holdings Announces Senior Management Appointment 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10

List of Tables

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Venn Life Sciences Holdings Plc, Deals By Therapy Area, 2012 to YTD 2018 9

Venn Life Sciences Holdings Plc, Medical Devices Deals, 2012 to YTD 2018 10

Venn Life Sciences Holdings Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

InnoVenn Raises USD1 Million in Venture Financing Round 12

Venn Life Sciences Raises USD 4 Million In Venture Financing 13

Venn Life Sciences Enters into Partnership with European Biotechnology Company 14

Venn Life Sciences Forms Joint Venture With Cellulac And Biopharmed West 15

Venn Life Sciences Forms Joint Venture In Russia 16

Venn Life Sciences And Encorium Announce Merger 17

Venn Life Sciences Raises USD0.9 Million in Private Placement of Shares 18

Venn Life Sciences to Raise USD5.5 Million in Private Placement of Shares 19

Venn Life Sciences Raises USD3.1 Million in Private Placement of Shares 20

Venn Life Sciences Raises USD1.7 Million in Private Placement of Shares 21

Venn Life Sciences Completes IPO For USD 4 Million 22

Venn Life Sciences Holdings to Acquire Remaining 11.03% Stake in Venn Life Sciences France 24

Integumen to Acquire Innovenn UK from Venn Life Sciences and Helium Rising Stars Fund for USD6 Million 25

Venn Life Sciences Acquires Kinesis Pharma 26

Venn Life Sciences Acquires Majority Stake in Cardinal Systems 27

Venn Life Sciences Acquires Labskin, SYN1113 And Related Equipment From Evocutis For USD 0.35 Million 28

Venn Life Sciences Acquires Medevol, Clinical Research Organization, For USD 1 Million 29

Venn Life Sciences To Acquire Majority Stake In CRM Clinical Trials For USD 0.8 Million 30

Armscote Investment Company Acquires Venn Life Sciences In Reverse Take-Over Transaction For USD 4.63 Million 31

Venn Life Sciences Holdings Plc, Key Competitors 32

Venn Life Sciences Holdings Plc, Key Employees 33

Venn Life Sciences Holdings Plc, Other Locations 34

Venn Life Sciences Holdings Plc, Subsidiaries 34

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Venn Life Sciences Holdings Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person